Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, Indiana.
Wes and Simone Chair of Cardiovascular Research, University of Missouri School of Medicine, Columbia, Missouri.
J Am Coll Cardiol. 2015 Apr 7;65(13):1340-1360. doi: 10.1016/j.jacc.2015.01.049.
Anticoagulation for atrial fibrillation has become more complex due to the introduction of new anticoagulant agents, the number and kinds of patients requiring therapy, and the interactions of those patients in the matrix of care. The management of anticoagulation has become a "team sport" involving multiple specialties in multiple sites of care. The American College of Cardiology, through the College's Anticoagulation Initiative, convened a roundtable of experts from multiple specialties to discuss topics important to the management of patients requiring anticoagulation and to make expert recommendations on issues such as the initiation and interruption of anticoagulation, quality of anticoagulation care, management of major and minor bleeding, and treatment of special populations. The attendees continued to work toward consensus on these topics, and present the key findings of this roundtable in a state-of- the-art review focusing on the practical aspects of anticoagulation care for the patient with atrial fibrillation.
由于新型抗凝药物的出现、需要治疗的患者数量和种类的增加，以及这些患者在治疗环境中的相互作用，心房颤动的抗凝治疗变得更加复杂。抗凝管理已成为一项“团队运动”，涉及多个专业领域在多个治疗场所的协作。美国心脏病学会通过其抗凝倡议，召集了来自多个专业领域的专家举行圆桌会议，讨论了对需要抗凝治疗的患者管理至关重要的话题，并就抗凝治疗的启动和中断、抗凝治疗质量、大出血和小出血的管理以及特殊人群的治疗等问题提出了专家建议。与会者继续就这些问题达成共识，并在一篇关注心房颤动患者抗凝治疗实际方面的最新综述中介绍了本次圆桌会议的主要发现。
